- Home
- CRBU vs FSP Comparison
CRBU vs FSP Comparison
Compare CRBU & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- FSP
- Stock Information
- Founded
- CRBU 2011
- FSP 1981
- Country
- CRBU United States
- FSP United States
- Employees
- CRBU N/A
- FSP N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- FSP Real Estate Investment Trusts
- Sector
- CRBU Health Care
- FSP Real Estate
- Exchange
- CRBU Nasdaq
- FSP Nasdaq
- Market Cap
- CRBU 203.9M
- FSP 165.9M
- IPO Year
- CRBU 2021
- FSP N/A
- Fundamental
- Price
- CRBU $2.08
- FSP $1.16
- Analyst Decision
- CRBU Strong Buy
- FSP
- Analyst Count
- CRBU 3
- FSP 0
- Target Price
- CRBU $9.33
- FSP N/A
- AVG Volume (30 Days)
- CRBU 4.6M
- FSP 819.7K
- Earning Date
- CRBU 11-07-2025
- FSP 10-28-2025
- Dividend Yield
- CRBU N/A
- FSP 3.48%
- EPS Growth
- CRBU N/A
- FSP N/A
- EPS
- CRBU N/A
- FSP N/A
- Revenue
- CRBU $9,121,000.00
- FSP $109,497,000.00
- Revenue This Year
- CRBU $8.06
- FSP $4.36
- Revenue Next Year
- CRBU N/A
- FSP $0.81
- P/E Ratio
- CRBU N/A
- FSP N/A
- Revenue Growth
- CRBU N/A
- FSP N/A
- 52 Week Low
- CRBU $0.66
- FSP $1.12
- 52 Week High
- CRBU $3.54
- FSP $2.21
- Technical
- Relative Strength Index (RSI)
- CRBU 39.13
- FSP 23.38
- Support Level
- CRBU $2.28
- FSP $1.39
- Resistance Level
- CRBU $3.53
- FSP $1.28
- Average True Range (ATR)
- CRBU 0.27
- FSP 0.06
- MACD
- CRBU -0.07
- FSP -0.01
- Stochastic Oscillator
- CRBU 7.81
- FSP 11.29
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.